Skip to main content
Log in

European Medical Association Smoking or Health (EMASH)-Konsensuspapier Rauchertherapie: Richtlinien für Ärzte

Smoking cessation: EMASH consensus

Arrêt du tabagsisme: Recommandations EMASH

Sozial- und Präventivmedizin

Zusammenfassung

Die hier vorliegende Arbeit fasst die aktuellen Erkenntnisse und therapeutischen Möglichkeiten der Rauchertherapie zusammen. Diese Richtlinien wurden von Experten der EMASH (European Medical Association Smoking or Health) erarbeitet. Die gezielte Diagnostik und Therapie der Nikotinabhängigkeit sind wesentliche Bestandteile einer erfolgreichen Abstinenz. Die Diagnostik mit Hilfe des Fagerström Tests zur Erhebung der Nikotinabhängigkeit (FTND) und die Möglichkeiten der Nikotinersatztherapie (Kaugummi, Pflaster, Nasenspray und Inhaler) werden genau erklärt. Zudem werden neue Symptome der Nikotinabhängigkeit beschrieben, die eine noch genauere Diagnostik ermöglichen (Nocturnal Sleep Disturbing Nicotine Craving, Nicotine Pre-Abstinence Syndrome).

Summary

The present study summarizes the latest scientific findings on smoking cessation and the various therapeutic possibilities. The guidelines presented here were compiled by the experts of EMASH (European Medical Association Smoking or Health). Accurate diagnosis and adequate treatment of nicotine dependence is essential for achieving sustained abstinence. Diagnostic procedures including the Fagerström Test for Nicotine Dependence (FTND) and various modes of nicotine replacement therapy (chewing gum, plaster, nasal spray and inhaler) are described. New symptoms of nicotine dependence (nocturnal sleep disturbing nicotine craving, nicotine pre-abstinence syndrome), that permit a more precise diagnosis, are discussed.

Résumé

Ce travail synthétise les connaissances et les possibilités thérapeutiques actuelles concernant la prise en charge des fumeurs. Ces recommendations ont été élaborées par des experts de l'EMASH (European Medical Association Smoking or Health). Un diagnostic ciblé ainsi qu'un traitement de la dépendance à la nicotine sont essentiels pour parvenir à une abstinence définitive. La méthode du diagnostic de dépendance à la nicotine (FTND) à l'aide du test Fagerström, et les possibilités d'une thérapie de remplacement de la nicotine (chewing-gum, patch, spray nasal et inhalateur0 sont décrites de façon détaillée. En outre, de noveaux symptômes de dépendance de la nicotine sont décrits, permettant un diagnostic encore plus précis (nocturnal sleep disturbing nicotine craving, nicotine pre-abstinence syndrome).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literaturverzeichnis

  1. Salto E, Nardini S, Cornuz J et al. Guidelines on Smoking Cessation for General Practitioners and other Health Professionals. European Medical Newsletter on Smoking Cessation 1997;15:2–6.

    Google Scholar 

  2. Kunze M, Schoberberger R, Abelin T et al. Rauchertherapie: Konsensus in den deutschsprachigen Ländern. Soz Präventivmed 1992;37:223–230.

    Google Scholar 

  3. WHO, A 5 year action plan. World Health Organization, Regional Office for Europe, Kopenhagen, 1988.

    Google Scholar 

  4. Schoberberger R, Kunze U, Schmeiser-Rieder A. Diagnostik und Therapie der Nikotinabhängigkeit. Versicherungsmedizin 1997;49:25–29.

    Google Scholar 

  5. Kunze M, Vutuc C. Threshold of Tar Exposure: Analysis of Smoking History of Male Lung Cancer Cases and Controls. In: Gori GB, Bock FG eds. Banbury Report 3: A Safe Cigarette? 1980: 29–34.

  6. Kunze U, Schoberberger R, Fagerström KO, Aigner K, Bölcskei P, Dittrich C. High Nicotine Dependence among Lung Cancer Patients. The European Respiratory Journal 1996;9:23.

    Google Scholar 

  7. Heatherton TF, Kozlowski LT, Frecker RC, Fagerström KO. The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. Br J Addict 1991;86: 1119–1127.

    Google Scholar 

  8. Schoberberger R. Psychological and physiological dependence. Vortrag anlässlich der 3rd International Conference on Preventive Cardiology. Oslo, 1993.

  9. Fagerström KO, Kunze M, Schoberberger R et al. Nicotine dependence versus smoking prevalence: comparisons among countries and categories of smokers. Tobacco Control 1996;6:52–56.

    Google Scholar 

  10. Schmeiser-Rieder A, Schoberberger R, Kunze U, Kunze M. Nocturnal sleep disturbing nicotine craving (NSDNC). Abstractband-Annual Scientific Conference of the Society for Research on Nicotine and Tobacco. Society for Research on Nicotine and Tobacco, 1996: 42.

  11. Prochaska J, DiClemente C. Self-change progress, self-efficacy and decisional balance across five stages of smoking cessation. In: Engstrom P ed. Advances in cancer control, 1993:131–140.

  12. Batra A, Fagerström KO. Neue Aspekte der Nikotinabhängigkeit und Raucherentwöhnung. Sucht 1997;4:277–288.

    Google Scholar 

  13. Tang JL, Law M, Wald N. How effective is nicotine replacement therapy in helping people to stop smoking? Br Med J 1994;308:21–26.

    Google Scholar 

  14. Fiore MC, Cohen SJ, Goldstein MG et al. Smoking cessation. Clinical Practice Guideline 1996; No 18, AHCPR 96-0692. US Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research.

  15. Silagy C, Mant D, Fowler G, Iodge M. Meta-analysis on efficacy of nicotine replacement therapies in smoking cessation. Lancet 1994;343:139–142.

    Google Scholar 

  16. Henningfield JE. Nicotine medications for smoking cessation. N Engl J Med 1995;18:1196–1203.

    Google Scholar 

  17. Fagerström KO. Efficacy of nicotine chewing gum: a review: In: Nicotine replacement: A Critical Evaluation. Pomerlau O and Pomerlau CS eds. New York: Alan R. Liss, 1988:109–128.

    Google Scholar 

  18. Hughes JR. Pharmacotherapy for smoking cessation: unvalidated assumptions, anomalies and suggestions for future research. J Consult Clin Psychol 1993;61:751–760.

    Google Scholar 

  19. Tonnesen P. Nicotine Replacement and Other Drugs in Smoking Cessation. In: Bolliger CT, Fagerström KO. eds. The Tobacco Epidemic. Progress in Respiratory Research. 1997;28:178–189.

  20. Fagerström KO, Sachs DPL. Medical management of tobacco dependence: a critical review of nicotine skin patches. Curr Pulmonol 1995;16:223–228.

    Google Scholar 

  21. Balfour DJK, Fagerström KO. Pharmacology of nicotine and its therapeutic use in smoking cessation and neurodegenerative disorders. Pharmacol Ther 1996;10:1–30.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kunze, U., Schmeiser-Rieder, A. & Schoberberger, R. European Medical Association Smoking or Health (EMASH)-Konsensuspapier Rauchertherapie: Richtlinien für Ärzte. Soz Präventivmed 43, 167–172 (1998). https://doi.org/10.1007/BF01359725

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01359725

Navigation